Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cefepime is a fourth-generation cephalosporin antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. A 2007 meta-analysis suggested when data of trials were combined, mortality was increased in people treated with…
Applications, Medical use & Chemistry
Explore the main themes, entities and connections around Cefepime. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
bacteria trade names pseudomonas activity drug medical meta-analysis mortality data administration aeruginosa spectrum use cephalosporin antibiotic gram-negative including streptococcus symptoms
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cefepime | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Cefepime | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Cefepime | ATC code | J01DE01 (WHO) | 1.00 | infobox |
| Cefepime | Bioavailability | 100% (IM) | 1.00 | infobox |
| Cefepime | CAS Number | 88040-23-7 Y | 1.00 | infobox |
| Cefepime | ChEBI | CHEBI:478164 Y | 1.00 | infobox |
| Cefepime | ChEMBL | ChEMBL186 Y | 1.00 | infobox |
| Cefepime | ChemSpider | 4586395 Y | 1.00 | infobox |
| Cefepime | CompTox Dashboard (EPA) | DTXSID70873208 | 1.00 | infobox |
| Cefepime | DrugBank | DB01413 Y | 1.00 | infobox |
| Cefepime | ECHA InfoCard | 100.171.025 | 1.00 | infobox |
| Cefepime | Elimination half-life | 2 hours | 1.00 | infobox |
| Cefepime | Excretion | Renal 70–99% | 1.00 | infobox |
| Cefepime | Formula | C19H24N6O5S2 | 1.00 | infobox |
| Cefepime | KEGG | D02376 Y | 1.00 | infobox |
| Cefepime | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Cefepime | Legal status | CA: ℞-only | 1.00 | infobox |
| Cefepime | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Cefepime | Legal status | US: ℞-only | 1.00 | infobox |
| Cefepime | License data | US DailyMed: Cefepime | 1.00 | infobox |
| Cefepime | MedlinePlus | a698021 | 1.00 | infobox |
| Cefepime | Melting point | 150 °C (302 °F) (dec.) | 1.00 | infobox |
| Cefepime | Metabolism | Hepatic 15% | 1.00 | infobox |
| Cefepime | Molar mass | 480.56 g·mol−1 | 1.00 | infobox |
| Cefepime | Pregnancy category | AU: B1 | 1.00 | infobox |
| Cefepime | Pronunciation | /ˈsɛfɪpiːm/ or /ˈkɛfɪpiːm/ | 1.00 | infobox |
| Cefepime | PubChem CID | 5479537 | 1.00 | infobox |
| Cefepime | Routes of administration | Intravenous, intramuscular | 1.00 | infobox |
| Cefepime | Trade names | Maxipime, Voco | 1.00 | infobox |
| Cefepime | UNII | 807PW4VQE3 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.